Pathogenic LRRK2 mutations in nuclear ageing—A new organelle to study in Parkinson's disease

E-ISSN： 1531-8257|28|10|1344-1345

ISSN： 0885-3185

Source： MOVEMENT DISORDERS, Vol.28, Iss.10, 2013-09, pp. : 1344-1345

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Motor phenotype of LRRK2‐associated Parkinson's disease: A tunisian longitudinal study

MOVEMENT DISORDERS, Vol. 30, Iss. 2, 2015-02 ,pp. : 253-258

John Wiley & Sons Inc

Access to resources Recommend Favorite

Disclosure of research results in genetic studies of Parkinson's disease caused by LRRK2 mutations

MOVEMENT DISORDERS, Vol. 30, Iss. 7, 2015-06 ,pp. : 904-908

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cognitive profile of LRRK2‐related Parkinson's disease

MOVEMENT DISORDERS, Vol. 30, Iss. 5, 2015-04 ,pp. : 728-733

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pathogenicity of LRRK2 P755L variant in Parkinson's disease

MOVEMENT DISORDERS, Vol. 23, Iss. 5, 2008-04 ,pp. : 734-736

John Wiley & Sons Inc

Access to resources Recommend Favorite

Glucocerebrosidase mutations and the pathogenesis of Parkinson disease

By Beavan Michelle S. Schapira Anthony H. V.

Annals of Medicine, Vol. 45, Iss. 8, 2013-12 ,pp. : 511-521

Informa Healthcare

Access to resources Recommend Favorite